Opening stock page...
Fetching company snapshot, pricing, and intelligence.
Intelligence coverage: 55%
Basic profile, financials, and market data are shown below. Deep research is building in the background.
AI confidence 70% · prior close shown (market closed)
Limited proprietary earnings coverage for TARA yet — signals will sharpen as filings and earnings are ingested.
Pipeline evidence · 17d ago
TARA's AlphaOS Signals
Upgrade to Pro for validated historical pattern analysis on TARA.
Free accounts see more of this; Premium sees all of it.
Updated
What happened recently for Protara Therapeutics, Inc. (TARA) — events, not interpretation.
Research & analysis only — not investment advice.
Investment snapshot
TARA's AI investment thesis
Upgrade to Premium for TARA's full multi-agent investment thesis.
Free accounts see more of this; Premium sees all of it.
Unified data coverage and cross-signal highlights — market, SEC, earnings, opportunity
Strengthen intelligence
Prior close
$3.28
Market cap
$193.83M
Profitable
No
Revenue $2.95M
Net income
$-57.44M
FY Dec 31, 2014
Loading Wall Street consensus…
Loading earnings intelligence…
Building technical intelligence snapshot — check back shortly.
Loading market context…
No price history. Sync market data to load charts.
Loading SEC filing intelligence…
No filings ingested yet.
US equity research on AlphaOS
Investment Snapshot above is the primary AlphaOS analysis for Protara Therapeutics, Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.
Research & analysis only — not investment advice. Price, charts, and filings are above.
Follow Protara Therapeutics, Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.
Connected companies and research pages from the AlphaOS knowledge graph.